If science and innovation hold the keys to tomorrow’s kingdoms, then their successful discovery, nurturing, and commercialisation will give advantage to the nations where they are found and built and in turn, offer the potential for significant investment opportunities.

Greg Smith, is CEO of IP Group, one of the UK’s very few specialised, publicly listed, investors in science and innovation.

In this episode, Greg explains IP’s business and opportunity set. He discusses UK innovation and where and why it is world class.

He explains sourcing opportunities, the investment process, and why he is so excited about their portfolio (covering firms such as Oxford Nanopore, Istesso, Pulmocide, Oxa & Hysata). 

He continues with discussing the hurdles in the UK to commercialising and retaining more of the great innovations found here, and assesses their early mover position. 

Finally he discusses the share price’s discount to NAV, and what may lie ahead.

Sign up to our Newsletter | Follow us on LinkedIn | Watch on YouTube | Contact IP Group